Peptide Therapeutics Market Reports Provides Sizes of Key Regional Markets using Yardsticks of Processes, Segments, Products, End User and Technology

The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. In addition, growing research and development activities along with a rich peptide therapeutics pipeline is expected to support the growth of the peptide therapeutics market. Patent expiration of several peptide drugs in the coming years will create ample opportunities for the global generic peptide therapeutics market to grow at a significant rate in the forecasted period. Peptides are made up of short chains of amino acid monomers. Peptide therapeutics have applications in several indications such as cancer, central nervous system disorders, respiratory disorders, and cardiovascular diseases; this is due to high selectivity, efficacy and safety of peptides.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/peptide-therapeutics-market/report-sample

Geographically, North America will be leading the global peptide therapeutics market in the coming years due to high prevalence of chronic diseases, high healthcare expenditure, and high research and development activities. In addition, advancements in the peptide manufacturing technology and rich peptide therapeutics pipeline are fueling the growth of peptide therapeutics market in North America region. Asia-Pacific is the fastest growing region in the global peptide therapeutics market. The major reasons for the fastest growth in the region are growing research and development activities, increasing prevalence of cancer and cardiovascular diseases, and increasing healthcare expenditure. Moreover, the peptide therapeutics market is growing rapidly due to the high generic drug market potential in the emerging economies, such as India and China.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=peptide-therapeutics-market

Some of the major players operating in the global peptide therapeutics market are, Sanofi, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Lonza Group Ltd., Merck & Co. Inc., Novo Nordisk A/S, F. Hoffmann-La Roche AG, Bachem Holding AG, PolyPeptide Group, and CordenPharma International GmbH.

Source:

P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Immunoassay Instruments Market Report Provides a Comprehensive Analysis of Market Trends, Technological Advancements, Company Profile and Growth Opportunities

The immunoassay instruments market is growing with a considerable rate due to rising incidence of chronic infectious diseases, increasing preference for personalized medicine, and technological advancements. Investments in emerging economies, and focus on developing compact, reliable and portable immunoassay instruments are some of the factors giving ample opportunities to the immunoassay instruments market to grow in the coming years.

Immunoassay is a laboratory based diagnostic procedure that is performed using an immunological reaction of antibodies. The formation of antibody antigen complexes in blood samples and other body fluids are measured by immunoassay instruments and are usually engaged to detect analytes in quantitative or qualitative manner. Qualitative analyses of immunoassay test include immunoassay tests by detecting human chorionic gonadotropin in urine samples for pregnancy. Immunoassay is done in multiple steps with reagents being added and washed away at different points during the assay.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/immunoassay-instruments-market/report-sample

Some of the factors driving the immunoassay instruments market are enhanced discovery of specific biomarkers, extensive use of immunoassays in oncology and rising geriatric population. Implementation of excise duty by the U.S. government and high cost associated with technologically advanced immunoassay systems are some of the factors restraining the immunoassay instruments market to some extent.

North America dominates the immunoassay instruments market due to expanding biotechnology and pharmaceutical industries, rising incidences of chronic diseases, government support and the launch of new products in the region. Asia-Pacific is expected to grow at the highest rate in the coming years.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=immunoassay-instruments-market

Some of the competitors in the immunoassay instruments market are Beckman Coulter, Inc., F. Hoffman-La Roche, Ltd., Thermo Fisher Scientific, Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation.

Source:

P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Home Healthcare Market Outlook, Opportunities, Challenges, Trends, Size and Growth, Competitive Analysis, Major Competitors and Porter Analysis

The global home healthcare market is growing significantly due to technological advancement and new healthcare services in the industry. Massive unexplored market in home healthcare industry of developing economies and cost effective alternatives to other modalities and facility based care are creating ample opportunities for the home healthcare market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are supporting to address the demand for cost effective healthcare in the home healthcare industry.

In healthcare industry, there is a trend of significant shift of treatment from hospitals to home in order to reduce healthcare expenditure. The massive global problem in the modern society is the increasing chronic diseases, such as stroke, kidney diseases and hypertension. According to Centers for Disease Control and Prevention, as of 2012 approximately 117 million U.S. people had one or more chronic health condition. Home healthcare market helps patients to treat or diagnose various chronic diseases at home.

Request to Get the Sample Pages at:  https://www.psmarketresearch.com/market-analysis/home-healthcare-market/report-sample

Geographically, North America will be leading the global home healthcare market in the coming years, due to rise in aging population, favourable reimbursement policies, and increasing sedentary lifestyle. Moreover, Asia-Pacific is the fastest growing region in the global home healthcare market. The major reasons for the fastest growth in the region are increasing healthcare expenditure and high standards of living of the consumers in the region. Moreover, the home healthcare market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China of Asia-Pacific region.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=home-healthcare-market

Some of the companies operating in the home healthcare market are 3M Healthcare, Becton Dickinson and Company, Baxter International, Inc., Abbott Laboratories, Hoffmann-La Roche Ltd., Philips Healthcare, Apria Healthcare Group, Inc., Johnson & Johnson Services, Inc., Bayer AG, Eli Lilly and Company, C.R. Bard, Inc., B. Braun Melsungen AG, Carefusion Corporation, Coloplast A/S, Convatec Inc., Medtronic, Inc., and GE Healthcare.

Source:

P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Coagulation Testing Market Comprehensive Review of its Applications, Demand, Growth Opportunities and Future Prospects

The increasing prevalence of various blood clotting disorders, such as deep vein thrombosis (DVT), hemophilia and thrombophilia, and growing aging population around the world are the predominant growth drivers for the global coagulation testing market. Additionally, the technological advancements in coagulation testing devices and initiatives taken by various government associations to raise awareness about various blood disorders and its management are also driving the growth of the market. The increasing numbers of mergers and acquisitions is one of the major trends observed in the market. In terms of testing service providers, hospitals hold the largest share in the global coagulation testing market.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/coagulation-testing-market/report-sample

North America and Europe are the major markets of coagulation testing, due to rapid launch of anticoagulants, increasing incidences of blood clotting disorders, and growing demand for coagulation testing devices. The U.S., followed by Canada is the largest market for coagulation testing in North America. Whereas, Germany, the U.K., France, and Italy are some of the major countries holding significant shares in the European market.  

The Asian market is growing with a significant rate, owing to increasing prevalence of blood disorders, growing aging population, and increasing healthcare spending in the region. In addition, the initiatives taken by various government associations to raise awareness about various blood disorders and its management are also supporting the growth of the Asian coagulation testing market. The countries, such as India, Japan, and China are the major markets in the region.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=coagulation-testing-market

Some of the major players operating in the global coagulation testing market include Alere Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens AG, F. Hoffmann-La Roche AG, Abbott, Axis-Shield Diagnostics Ltd., Danaher Corporation, Becton, Dickinson and Company, Bio/Data Corporation, and Chrono-Log Corporation.

Uterine Fibroid Treatment Market Comprehensive Review of its Applications, Demand, Growth Opportunities and Future Prospects

The global uterine fibroid treatment market is witnessing considerable growth due to increasing female geriatric population, increasing healthcare expenditure, increasing prevalence of obesity, launch of technologically advanced fibroid treatment products and growing popularity of minimally invasive treatments. Moreover, growing prevalence of hormonal disorders or hormonal imbalance leading to fibroid formation is supporting the growth of the market. The increasing adoption of uterine fibroid treatment across the globe, owing to increasing incidence of cancer is also driving the growth of the market.

Request to Get the Sample Report at: https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market/report-sample

Geographically, North America has been the largest market for uterine fibroid treatment, owing to its increased awareness, established healthcare industry, and easy accessibility to advanced technologies due to the presence of high number of hospitals, clinics and ambulatory surgical centers in the region. The U.S. contributed largest revenue to the North American as well as global uterine fibroid treatment market. The increased patient pool undergoing hormonal disorders and increasing prevalence of uterine cancer is the key growth driving factor for the U.S. uterine fibroid treatment market.

The key players operating in the global market are Boston Scientific Corporation, CooperSurgical, Inc., Karl Storz, Halt Medical, Inc., Merit Medical Systems, LiNA Medical USA, Olympus Corporation, and Richard Wolf GmbH.

For more Info:

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Biobanking Market by Sample Type, Services, Application and Storage: Global Market Size, Growth Opportunities and Future Prospects

Biobanks are biological repository of human samples and related data which is utilized in biological research for investigating therapeutic approaches to ameliorate various diseases. Bio-specimens are characterized to determine the features of a continuous cell line, identification of contaminants and gaining profound knowledge of the raw materials utilized in the preparation of the bio-products. The process of collection of these specimens and extraction of useful information into a repository for research purposes is known as biobanking. The global biobanking market is expected to witness significant growth during the forecast period (2017-2023), on account of impact of various factors such as rise in on-going genomic research of several diseases, technological advancements with respect to biobanking, funding from government and private organizations, and the growing trend of cord blood repository of new born. However, sustaining the biobanks for a long term is a major challenge faced by the biobanking market.

Request to Get the Sample Report at: http://bit.ly/2H4BfB3

Globally, North America is the largest market for biobanking followed by Europe, due to the involvement of government organization in funding research& development of regenerative medicines, cell and gene therapy. Additionally, growing research in the area of genomics and proteomics; inclination towards personalized medication and entry of new biotechnology and pharmaceutical companies also drives the growth of North America biobanking market. Further, the developing countries of Asia-Pacific such as Japan, China and India are expected to witness the highest growth during the forecast period. Major factors driving the growth of the Asia-Pacific biobanking market include rise in government initiatives to focus on the life-science research and funding for development of biomedical, pharmaceutical and biotechnological industry.

Some of the major key players operating in the biobanking market include Thermo Fisher Scientific Inc., PHC Holdings Corporation (Panasonic Healthcare Holdings Co. Ltd), Qiagen N.V., Merck KGaA, Brooks Automation. Inc., Hamilton Company, Becton, Dickinson and Company, Greiner Holding AG, BioLife Solutions, Inc., Promega Corporation.

Source:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Healthcare Industry Growth with Cardiovascular Information System Market - Market Outloook

The global cardiovascular information system market is witnessing significant growth due to increasing prevalence of cardiovascular diseases, growing government initiates towards electronic health record system implementation and growing rate of medication errors. The remote access to data and images, and reduced IT burden in the diagnostic center and hospitals are supporting the demand of CVIS. Moreover, better interoperability and increasing healthcare cost are further expected to boost the market. Based on mode of operation, web-based segment leads the global market in terms of size, owing to high rate of awareness, improved interoperability, reduced IT burden in hospitals and relatively less cost. Based on component, the market for service segment is expected to grow at the fastest rate during the forecast period, due to upgradation of services for the complex software introduction and requirement for extensive training.

Request to Get the Sample Report at: http://bit.ly/2HhfZrc

Geographically, North America has been the largest market for cardiovascular information system, owing to increasing incidence of cardiovascular disease, well established healthcare infrastructure, and strict privacy and security regulation in the region. The U.S. contributed largest revenue to the North American as well as global cardiovascular information system market. The increase in integration of the electronic health record maintenance system and favorable government policies are driving the growth of the U.S. cardiovascular information system. Globally, the cardiovascular information system market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to large pool of patient, improving healthcare infrastructure, increasing incidence of cardiovascular disease, and growing medical tourism in the region.

The key players operating in the global cardiovascular information system market are Philips Healthcare, McKesson Corporation, Philips Healthcare, General Electric Company, Siemens AG, AGFA Healthcare and Cerner Corporation.

Healthcare Industry Growing with Patient Engagement Solutions Market | Market Size, Growth Opportunities and Demand

The global patient engagement solutions market is growing considerably, due to growing medical tourism and increasing cloud based models. During the forecast period, the software segment is expected to report the largest share, among all the components segments of the patient engagement solution market. Among the various delivery modes, the web based delivery segment leads the market, as it is cost effective and user friendly; however, the cloud based delivery segment is expected to grow with the fastest rate during the forecasted period. Among the various applications, the health management segment leads the global patient engagement solutions market. Based on therapeutics area, the chronic diseases segment leads the market in terms of size and is expected to grow with the fastest rate during the forecast period. Among the various end users, the providers segment led the market in 2014.

Request to Get the Sample Report at: http://bit.ly/2JEEv3Q

Geographically, North America is expected to dominate the global market in the coming years, due to growing geriatric population, implementation of Affordable Care Act, and increasing prevalence of chronic diseases. Asia is expected to be the fastest growing region, due to growing medical tourism and increasing healthcare awareness in the region. In addition, the Asian market of patient engagement solutions is growing due to increasing healthcare expenditure and increasing healthcare information technology adoption in the emerging countries, such as India and China.

Some of the companies operating in the global patient engagement solutions market are Mckesson Corporation, Athenahealth Inc., Medecision Inc., Cerner Corporation, Oneview healthcare, get Real Health, Welvu, Inc., Orion Health Ltd., Patientpoint, Lincor Solutions Ltd., EMMI Solutions LLC., Allscripts Healthcare Solutions Inc., Getwellnetwork Inc., and Phytel Inc.

Nonalcoholic Steatohepatitis Therapeutics Market Comparison Analysis and Demand Forecast to 2023

The global nonalcoholic steatohepatitis (NASH) therapeutics market is expected to witness significant growth due to current unmet medical need of NASH, scarcity of the permanent treatment of the disease, increasing prevalence of obesity, and high demand for safe and effective medication. The regulatory bodies are supporting the NASH market by providing designations and funding for speeding up the drug development process. In March 2015, obeticholic acid, an investigational Phase III clinical trial drug candidate of Intercept Pharmaceuticals Inc., received breakthrough therapy designation from the U.S. Food and Drug Administration for the treatment of patients with NASH.

Request to Get the Sample Report at: http://bit.ly/2JzCeH6

Geographically, North America is expected to be the largest market for NASH therapeutics owing to the large number of research and development activities, high healthcare expenditure and high incidence of obesity. The U.S. contributed largest revenue to the North American market and it is expected to remain the largest market globally, during the forecast period.

Some of the key players operating in the global NASH therapeutics market are Genfit SA, Gilead Sciences, Inc., Novo Nordisk A/S, Intercept Pharmaceuticals, Inc., Enzo Biochem, Inc., Raptor Pharmaceutical Corp., Conatus Pharmaceuticals Inc., Zydus Cadila Healthcare Limited., Novartis AG, and Shire plc.

Hospital Infection Therapeutics Market is increasing at a significant rate | Global Industry Scope in Future

The hospital infection therapeutics market is increasing at a significant rate, due to high susceptibility of neonatal population in healthcare setting and high occurrence of numerous hospital infections. Increasing incidences of hospital infections, high number of pipeline drug molecules for specific treatment of healthcare associated infections and high unaddressed needs in most of the countries are some of the factors providing ample opportunities for the hospital infection therapeutics market to grow in the coming years.

North America leads the Hospital Infection Therapeutics Market followed by Europe. The North America hospital infection therapeutics market leads, due to improved healthcare awareness, high ratio of hospitals as compared to population of the region, increasing count of multi drug resistant microbial pathogens and increase in aging population of the region. Asia-Pacific is growing with an exponential rate, due to increased incidences of hospital infections and high demands of therapeutic drugs in the emerging countries such India and China.

Request to Get the Sample Report at: https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market/report-sample

On the basis of infection types, the hospital infection therapeutics market can be categorized into hospital acquired pneumonia, urinary tract infections, bloodstream infections, surgical site infections and gastrointestinal disorders. Hospital acquired pneumonia leads the global hospital infection therapeutics market, under the types of infection categories. While urinary tract infections are expected to grow at an exponential rate in the coming years.

Some of the competitors in the hospital infection therapeutics market are: Cubist Pharmaceuticals, Inc., Actavis PLC, Johnson & Johnson Services, Inc., Bayer AG, GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Merck & Co., Inc., AstraZeneca PLC, Pfizer, Inc. and Sanofi.

Medical Waste Management Market | Global Trend & Research Report

Medical waste refers to the waste originated within medical amenities such as hospitals, clinics, veterinary hospitals/clinics, dental practices, physician's offices, laboratories, blood banks and research and development centers (R&D) related to healthcare. The Medical Waste Management Market program is critical for the public health, environment, and sanitation. Unlike municipal waste treatment the medical waste management involves various stages of waste management, such as accumulation, generation, storage, handling, treatment, transport, and disposal.

Stringent environment and health safety regulation by governments worldwide, and the growth of pharmaceuticals and healthcare industry in developing market, are some of the predominant drivers of the medical waste treatment market. In the U.S. the government has regulated the medical water treatment under U.S. Environmental Protection Agency’s (EPA) Resource Conservation and Recovery Act (RCRA).

Request to Get the Sample Report at: http://bit.ly/2JmOPxi

Based on the different business sector the global medical waste management market can be bifurcated as:

• Hospital Waste Management
  • Anatomical Waste Management
  • Regular Medical Waste Management
• Pharmaceutical Waste Management
  • Clinical Trial Waste Management
  • Manufacturing Waste Management

On the basis of various services under medical waste treatment the global medical waste treatment market can be classified as:

• Collection, Transportation, and Storage
• Waste Treatment
• Disposal/Recycling

On the basis of waste treatment technology the global medical waste treatment market can be segmented as:

• Mechanical
• Chemical
• Thermal
• Others

Some of the major players operating in global medical waste management market include, Clean Harbors, Inc., Hawaii Bio-Waste Systems Inc. (HBW), Healthcare Environmental Services Group, Medclean Technologies Inc., Medasend Biomedical Inc., Miller Group, Republic Services Inc., Suez Environnement, Waste Management Inc., Aipura LIC, Stericycle Inc. and Gamma Waste Systems.

Report Coverage

• Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
• Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
• Uncovers potential demands in the market

Urinalysis Market Size, Share, Development, Growth and Demand Forecast to 2023

The Global Urinalysis Market is witnessing considerable growth due to increasing prevalence of diabetes, increasing geriatric population, increasing prevalence of kidney diseases and growing urinary tract infections (UTI). Moreover, increasing healthcare expenditure increases the affordability of patients leading to the increased sales of urinalysis products, supporting the growth of the market. Based on product, the consumables segment is expected to grow at a faster rate during the forecast period, compared to instrument segment. The increasing adoption of dipsticks across the globe owing to their ease of use, cheaper price and easy availability over the counter (OTC) is driving the growth of this segment.

The rapid growth in emerging economies and technological development in the in vitro diagnostics industry with the advent of portable and battery operated urinalysis device is expected to create revenue generation opportunities for the manufacturers of urinalysis products. However, high cost of urinalysis equipment and stringent regulatory requirements are the key factors hampering the growth of the global market.

Increase in diabetic cases leads to increased sales of urinalysis dipsticks, disposables and devices across the globe. For instance, according to the World Health Organization (WHO) the global diabetes prevalence has increased from 4.7% to 8.5% from 1980 to 2014, respectively. As per International Diabetes Federation (IDF), Western Pacific (WP) region consists of maximum diabetes cases; its prevalence was 138 million cases in 2014, which is expected to reach 202 million in 2035. Similarly, according to IDF, the prevalence of diabetes in South-East Asia (SEA) is expected to increase from 75 million in 2014 to 123 million in 2035.

Request sample copy of report here : https://bit.ly/2Jdq0Uo

Urinalysis is a screening test which includes visual, chemical and microscopic examinations used to detect the presence of substances such as crystals or casts, cells, and cell fragments in the urine. It is widely adopted across the globe to detect liver problems, UTI, diabetes and pregnancy in patients.

Geographically, North America has been the largest market for urinalysis, owing to increased awareness, growth of aged pool, established healthcare industry, and easy accessibility to advanced technologies. The U.S. contributed largest revenue to the North American as well as global urinalysis market. The presence of large pool of patients undergoing pregnancy test and wide acceptance of point of care diagnostic devices are the key growth driving factor for the U.S. urinalysis market.

Europe has been the second largest market for urinalysis, where the market is driven by the presence of a large pool of patients suffering from diabetes, increasing healthcare expenditure and rapidly developing healthcare infrastructure. In 2015, Germany lead the European urinalysis market and it is also expected to grow at the fastest rate in Europe, during forecast period. Globally, the urinalysis market in Asia-Pacific would witness highest growth during the forecast period. The highest growth in the region is attributed to the increasing prevalence of kidney diseases, increasing per capita income leading to improved standard of living, increasing healthcare spending, growing demand for better quality medical care, and awareness about urinalysis tests in the region. In addition, increasing demand for pregnancy test further drives the market growth in the region.

The key players operating in the global urinalysis market are F. Hoffmann-LA Roche AG, Danaher Corporation, Siemens AG, Sysmex Corporation, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Acon Laboratories, Inc., Arkray, Inc. and Urit Medical Electronic Group Co., Ltd.